BioSIM 抗人 CD38 抗体，生物类似药 5mg

BioSIM 抗人 CD38 抗体（生物类似药，科研用途）

产品概述

本产品为科研级生物类似药，对应参考抗体为MOR-202，英文名称：BioSIM anti-Human CD38 Antibody (MOR-202 Biosimilar), Research Grade，专为生命科学基础研究设计，不用于临床诊断或治疗。

核心参数

• 产品类型：二抗
• 供应商：InvivoCrown
• 产品货号：SIM0180-5mg
• 产品规格：5mg/支
• 来源宿主：Human（具体为全人源或人源化需参考产品说明书）
• 反应性：仅针对Human（人）CD38抗原
• 免疫原：详细信息请查阅产品配套说明书

生产工艺特点

本重组抗体采用严格的工艺控制，确保产品一致性与低背景干扰：

• 全程在无动物成分的生产设施中生产，避免外源性动物源污染物引入
• 采用体外无蛋白细胞培养技术，减少非目标蛋白对实验的干扰
• 经多步骤纯化工艺，包含Protein A或G亲和色谱核心步骤，提升抗体纯度

研究应用场景

目标疾病研究方向

• 多发性骨髓瘤（MM）
• 特发性膜性肾病
• 免疫球蛋白A肾病

适用实验类型

• ELISA（酶联免疫吸附实验）
• FACS（荧光激活细胞分选）
• Functional assay（细胞功能学实验）
• Research in vivo（体内研究，需结合实验体系验证适用性）

保存与运输建议

为维持抗体活性与稳定性，需严格遵循以下条件：

• 短期使用（1-2周）：4°C避光保存，避免反复开盖
• 中短期储存（≤12个月）：-20°C避光保存，建议分装为小体积（如100μL/管）以减少冻融
• 长期储存（>12个月）：-80°C避光保存，分装后可长期维持活性
• 运输注意事项：建议采用干冰冷链运输，收到后立即转移至对应储存温度

供应商支持

供应商：InvivoCrown

如需获取产品说明书、技术验证数据或定制化需求，请联系供应商官方渠道。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM anti-Human CD38 Antibody (Biosimilar, for Research Use)

Product Overview

This product is a research-grade biosimilar with the reference antibody MOR-202, English name: BioSIM anti-Human CD38 Antibody (MOR-202 Biosimilar), Research Grade, specifically designed for basic life science research, not for clinical diagnosis or therapy.

Core Parameters

• Product Type: Secondary Antibody
• Supplier: InvivoCrown
• Catalog Number: SIM0180-5mg
• Specification: 5mg/vial
• Host Species: Human (Please refer to the product manual for details on fully human or humanized)
• Reactivity: Specifically against Human CD38 antigen
• Immunogen: Please refer to the accompanying product manual for detailed information

Production Process Characteristics

This recombinant antibody is manufactured using strict process controls to ensure product consistency and low background interference:

• Produced entirely in animal component-free production facilities to avoid introduction of exogenous animal-derived contaminants
• Utilizes in vitro protein-free cell culture technology to reduce interference from non-target proteins in experiments
• Undergoes a multi-step purification process, including core steps of Protein A or G affinity chromatography to enhance antibody purity

Research Application Scenarios

Target Disease Research Directions

• Multiple Myeloma (MM)
• Idiopathic Membranous Nephropathy
• Immunoglobulin A Nephropathy

Applicable Experiment Types

• ELISA (Enzyme-Linked Immunosorbent Assay)
• FACS (Fluorescence-Activated Cell Sorting)
• Functional assay (Cell functional experiments)
• Research in vivo (In vivo research, requires verification of applicability in combination with experimental systems)

Storage and Transportation Recommendations

To maintain antibody activity and stability, the following conditions must be strictly followed:

• Short-term use (1-2 weeks): Store at 4°C protected from light, avoid repeated opening of the cap
• Medium to short-term storage (≤12 months): Store at -20°C protected from light, aliquoting into small volumes (e.g., 100μL/tube) is recommended to reduce freeze-thaw cycles
• Long-term storage (>12 months): Store at -80°C protected from light, activity can be maintained long-term after aliquoting
• Transportation Notes: Dry ice cold chain transportation is recommended, transfer to appropriate storage temperature immediately upon receipt

Supplier Support

Supplier: InvivoCrown

For product manuals, technical validation data, or customization requirements, please contact the supplier through official channels.

Note: The above information may change due to product optimization and upgrades. Please consult InvivoCrown for specific information.